According to the latest information from the Hong Kong Stock Exchange, JPMorgan Chase & Co. sold approximately 874,052 shares of SINOPHARM (01099) on June 30.

The transaction was executed at a price of HK$16.0054 per share, resulting in a total consideration of roughly HK$13.99 million.

Following this divestment, JPMorgan's holding in the company now stands at about 80.1123 million shares, representing a stake of 5.97%.